Medifast to Pay SEC Penalty of $200,000 Over Financial Restatements

Weight-loss solution provider Medifast (NYSE: MED  ) has agreed to settle with the Securities and Exchange Commission over the restatement of certain items in financial records from 2006 to 2009, the company announced today.

Medifast said the SEC took into consideration a series of steps taken by the company to rectify the situation, including retaining certain executives and accounting personnel. Under the terms of the settlement, Medifast will pay a civil penalty of $200,000 to the SEC. Additionally, without admitting or denying the SEC's findings, the company has consented to a cease and desist order from the SEC.

Since the beginning of 2013, Medifast has seen its stock price rise from $26.39 to a peak of $29.32 per share. Currently, the company trades at $26.08.

link


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2645889, ~/Articles/ArticleHandler.aspx, 10/25/2014 6:52:03 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement